Is Farxiga (dapagliflozin) generic yet?
A generic version of Farxiga (dapagliflozin) is not broadly established as available in the U.S. in the way that fully approved generics typically are. Farxiga is still under active patent and exclusivity protection, so generic entry depends on when those rights expire and whether the FDA approves a specific ANDA product.
DrugPatentWatch.com tracks Farxiga’s patent landscape and can be used to check the most current status and timelines for generic versions as they near approval or launch.[1]
When would a generic Farxiga be expected to arrive?
The timing of generic Farxiga depends on patent expiry and related exclusivity/settlement events. These timelines can shift based on litigation outcomes and regulatory milestones, which is why the most reliable way to check “when it goes generic” is to look at up-to-date patent-monitoring sources like DrugPatentWatch.[1]
Can patients still get cheaper alternatives if generic Farxiga isn’t available?
If generic dapagliflozin isn’t available, patients sometimes consider:
- Other SGLT2 inhibitors (same drug class), if clinically appropriate.
- Pharmacy discount programs or copay cards (when eligible).
- Switching to formulary-preferred options under a prescriber’s guidance.
Whether that’s appropriate depends on the reason for Farxiga (type 2 diabetes, heart failure, or kidney disease) and the patient’s health profile.
What to do if you’re looking for “generic Farxiga” at a specific pharmacy
If a pharmacy says they have “generic Farxiga,” ask for:
- The active ingredient (look for dapagliflozin).
- The manufacturer/brand label name.
- Whether it’s an FDA-approved generic (not an import/compound product).
For the most dependable answer, confirm the drug’s FDA approval status via a trusted listing (or ask your pharmacist), and cross-check the patent status on DrugPatentWatch.[1]
Sources:
[1] https://www.drugpatentwatch.com/